Skip to content

Opening book details…

About this Medicine article

Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial by Welzel, Tania M; Asselah, Tarik; Dumas, Emily O; Zeuzem, Stefan; Shaw, David; Hazzan, Rawi; Forns, Xavier; Pilot-Matias, Tami; Lu, Wenjing; Cohen, Daniel E; Feld, Jordan J is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Welzel, Tania M; Asselah, Tarik; Dumas, Emily O; Zeuzem, Stefan; Shaw, David; Hazzan, Rawi; Forns, Xavier; Pilot-Matias, Tami; Lu, Wenjing; Cohen, Daniel E; Feld, Jordan J
Publisher
Elsevier ; Elsevier Limited; Elsevier BV (ISSN 2468-1253)
Published
2017
Field
Medicine (Health Sciences)

More by Welzel, Tania M; Asselah, Tarik; Dumas, Emily O; Zeuzem, Stefan; Shaw, David; Hazzan, Rawi; Forns, Xavier; Pilot-Matias, Tami; Lu, Wenjing; Cohen, Daniel E; Feld, Jordan J

Browse all works by Welzel, Tania M; Asselah, Tarik; Dumas, Emily O; Zeuzem, Stefan; Shaw, David; Hazzan, Rawi; Forns, Xavier; Pilot-Matias, Tami; Lu, Wenjing; Cohen, Daniel E; Feld, Jordan J